BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3181191)

  • 1. An improved method for the in vivo labelling of red blood cells with 99mTc in gated cardiac imaging.
    Bekdik CF; Ercan MT; Bernay I; Caner BE; Turguter S
    Eur J Nucl Med; 1988; 14(7-8):408-10. PubMed ID: 3181191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure in labelling of red blood cells with 99mTc: interaction between intravenous cannulae and stannous pyrophosphate.
    Millar AM; Wathen CG; Muir AL
    Eur J Nucl Med; 1983; 8(11):502-4. PubMed ID: 6317393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a simpler technique for in-vivo labelling of red blood cells with 99mTc.
    Rehani MM; Sapru RP; Chopra VK; Sharma RR; Wahi PL
    Nuklearmedizin; 1980 Feb; 19(1):22-4. PubMed ID: 7402940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of in vitro labeling method for human use of heat-damage red blood cells to detect splenic tissue and hemocateretic function.
    Sammartano A; Scarlattei M; Migliari S; Baldari G; Ruffini L
    Acta Biomed; 2019 Sep; 90(3):275-280. PubMed ID: 31580314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo labelling of RBC with 99mTc for blood pool imaging using different stannous radiopharmaceuticals.
    Popescu HI; Lessem J; Erjavec M; Füger GF
    Eur J Nucl Med; 1984; 9(7):295-9. PubMed ID: 6088238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labeling of red blood cells with Tc-99m after oral administration of SnCl2: concise communication.
    Patel MC; Parab PB; Samuel AM; Ganatra RD
    J Nucl Med; 1979 Aug; 20(8):877-81. PubMed ID: 541736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m labeling by means of stannous pyrophosphate: application to bleomycin and red blood cells.
    Bardy A; Douyé H; Gobin R; Beydon J; de Tovar G; Pannecière C; Hégésippe M
    J Nucl Med; 1975 May; 16(5):435-7. PubMed ID: 53279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro RBC labeling with the UltraTag RBC kit versus in vivo labeling.
    Patrick ST; Glowniak JV; Turner FE; Robbins MS; Wolfangel RG
    J Nucl Med; 1991 Feb; 32(2):242-4. PubMed ID: 1992026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical parameters of in vivo red blood cell labeling with Technetium-99m.
    Zimmer AM; Pavel DG; Karesh SM
    Nuklearmedizin; 1979 Dec; 18(5):241-5. PubMed ID: 547251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kit-labeled technetium-99m red blood cells (Tc-99m-RBC's) for clinical cardiac chamber imaging.
    Larson SM; Hamilton GW; Richards P; Ritchie JL
    Eur J Nucl Med; 1978; 3(4):227-31. PubMed ID: 720352
    [No Abstract]   [Full Text] [Related]  

  • 11. A simple and efficient method of labelling RBCs with 99mTc for spleen imaging.
    Ercan MT; Bernay I
    Int J Rad Appl Instrum B; 1990; 17(3):335-9. PubMed ID: 2341290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gated blood pool imaging following 99mTc stannous pyrophosphate imaging.
    Stokely EM; Parkey RW; Bonte FJ; Graham KD; Stone MJ; Willerson JT
    Radiology; 1976 Aug; 120(2):433-4. PubMed ID: 935500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pitfall to modified in vivo method of technetium-99m red blood cell labeling. Iodinated contrast media.
    Tatum JL; Burke TS; Hirsch JI; Miller WW; Fratkin MJ
    Clin Nucl Med; 1983 Dec; 8(12):585-7. PubMed ID: 6653013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac blood pool imaging--a clinical comparison between red blood cells labeled with 99mTc in vivo and in vitro and 99mTc-labeled human serum albumin.
    Dahlström JA; Carlsson S; Lilja B; Mattsson S; Pettersson C
    Nuklearmedizin; 1979; 18(6):271-3. PubMed ID: 537922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo labelling of granulocytes with 99mTc anti-NCA monoclonal antibodies for imaging inflammation.
    Joseph K; Höffken H; Bosslet K; Schorlemmer HU
    Eur J Nucl Med; 1988; 14(7-8):367-73. PubMed ID: 3181186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to label red blood cells adequately in daily practice using an in vivo method: methodological and clinical considerations.
    Hambye AS; Vandermeiren R; Vervaet A; Vandevivere J
    Eur J Nucl Med; 1995 Jan; 22(1):61-7. PubMed ID: 7698157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kit for labelling erythrocytes or leukocytes with technetium-99m.
    Proulx A; Gerson B; Ballinger JR; Gulenchyn KY
    Int J Rad Appl Instrum B; 1990; 17(5):515-7. PubMed ID: 2391248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can technetium 99m bisdiethylphosphinoethanebis-t butylisocyanide (99mTc-DEPIC) be used for routine radionuclide ventriculography?
    de Klerk JM; van Rijk PP; van Dongen AJ; Deenstra M; Bànki JH; van het Schip AD
    Eur J Nucl Med; 1991; 18(5):317-20. PubMed ID: 1936039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An investigation of factors that induce low efficiency of 99mTc-RBC in vivo labeling--with special reference to the effect of the reaction between 99mTcO4- and SnCl2 remaining in the three-way cock].
    Narahashi S; Yuda I; Nakamura M; Nishimura S; Yasunaga H; Morita K; Yamaguchi H
    Kaku Igaku; 1986 May; 23(5):505-11. PubMed ID: 3016387
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxygen-dependent circulation of sickle erythrocytes.
    Castro O; Osbaldiston GW; Aponte L; Roth R; Orlin J; Finch SC
    J Lab Clin Med; 1976 Nov; 88(5):732-44. PubMed ID: 988104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.